Novacyt investor relations
WebJun 30, 2024 · Novacyt SA Graham Mullis, Chief Executive Officer James McCarthy, Chief Financial Officer +44 (0)1276 600081 SP Angel Corporate Finance LLP (Nominated Adviser and Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470 0470 Numis Securities Limited (Joint Broker) WebJun 1, 2024 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual Report and Accounts ("Annual Report") for the year ended 31...
Novacyt investor relations
Did you know?
WebNovacyt is a diagnostics group, manufacturing diagnostic and pathogen testing kits based on molecular and protein testing technologies sold into human clinical, life science, food … WebNOVACYT has 8 current employee profiles, including Chief Executive Officer Graham Mullis. Graham Mullis Chief Executive Officer Anthony Dyer Chief Corporate Development Officer Ruth Powell Managing Director of NOVAprep & Lab21 Services Paul Eros Corporate Business Development Director Mandy Cowling Corporate & Investor Relations Manager
WebJul 7, 2024 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces a trading update for the half year ended 30 June 2024 … WebNovacyt Company Profile. Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to …
WebNovacyt (NVYTF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the ticker LSE:NCYT . NOVACYT is funded by 4 investors. Kreos Capital and YA Global Master SPV are the most recent investors. NOVACYT has acquired 4 organizations.
WebFeb 10, 2024 · Investor Relations Novacyt SA ALNOV Ownership Morningstar Rating Rating as of Feb 10, 2024 Quote Chart Stock Analysis News Price vs Fair Value ...
WebNovacyt Group (UK) Unit 1, Watchmoor Point, Watchmoor Road, Camberley, Surrey GU15 3AD. T +44 (0) 1276 600081. F +44 (0) 1276 600151. E [email protected]. … phitz and grayWebNovacyt SA Graham Mullis, Chief Executive Officer James McCarthy, Chief Financial Officer +44 (0)1276 600081 SP Angel Corporate Finance LLP (Nominated Adviser and Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470 0470 Numis Securities Limited (Joint Broker) phi\\u0027s auto body and repairWebNovacyt is an innovative high growth diagnostic group of companies founded in 2005 and focused on the design, manufacture and supply of a growing portfolio of oncology and infectious disease diagnostic products. They are passionate about their business and the healthcare industry sector they work with and would like to thank you for your ... ts shara powerestWebPlease get in touch using the details below. Alternatively, use the direct contact form below. We’re looking forward to hearing from you Mandy Cowling Corporate & Investor Relations … Advisor and Investor Contacts; AIM Rule 26 information; Corporate Governance; Our … Company York House, School Lane, Chandlers Ford, Eastleigh, SO53 4DG … phit workoutsWebJun 1, 2024 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual Report and Accounts ("Annual Report") for the year ended 31... ts shara nobreak 2200WebMar 24, 2024 · NOVACYT : Press releases relating to NOVACYT Investor relations Euronext Paris: ALNOV Euronext Paris phit workoutWebMar 24, 2024 · Investor Relations Novacyt SA NCYT Ownership Morningstar Rating Rating as of Mar 24, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... phitz violin case waterproof